Hakan Eroğlu (Hakan Eroglu)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Silver Nanoparticles

Wastewater Treatment

Top Venues

Journal of drug targeting

This page only lists publications with an associated author ORCID identifier.

Publications

Aslıhan Arslan, Barbaros Yet, Emirhan Nemutlu, Yagmur Akdag, Hakan Eroğlu, Levent Oner
Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation. Pharmaceutics 15 (2) (2023)
Aslıhan Arslan, Barbaros Yet, Emirhan Nemutlu, Yagmur Akdag, Hakan Eroğlu, Levent Oner
Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation. Pharmaceutics 15 (2) (2023)
Aslıhan Arslan, Barbaros Yet, Emirhan Nemutlu, Yagmur Akdag, Hakan Eroğlu, Levent Oner
Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation. Pharmaceutics 15 (2) (2023)
Aslıhan Arslan, Barbaros Yet, Emirhan Nemutlu, Yagmur Akdag, Hakan Eroğlu, Levent Oner
Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation. Pharmaceutics 15 (2) (2023)
Betul Topcu, Merve Gultekinoglu, Selin Seda Timur, Ipek Eroglu, Kezban Ulubayram, Hakan Eroğlu
Current approaches and future prospects of nanofibers: a special focus on antimicrobial drug delivery. Journal of drug targeting 29 (6) (2021)
Gizem Tezel, Selin Seda Timur, Filiz Kuralay, R Neslihan Gürsoy, Kezban Ulubayram, Levent Oner, Hakan Eroğlu
Current status of micro/nanomotors in drug delivery. Journal of drug targeting 29 (1) (2020)